Cited by 344Alzheimer's disease research and treatmentsRedox biology and oxidative stressDementia and Cognitive Impairment Research

The DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.

Causes of oxidative stress in Alzheimer disease

Open access

Zhu, X., Su, B., Wang, X., Smith, M. A., Perry, G.·2007·Cellular and Molecular Life Sciences

DOI 10.1007/s00018-007-7218-4PMC PMC11136009

Open this paper in CoChat — free account

Abstract

Oxidative stress is one of the earliest events of Alzheimer disease (AD), with implications as an important mediator in the onset, progression and pathogenesis of the disease. The generation of reactive oxygen species (ROS) and its consequent cellular damage/response contributes to much of the hallmark AD pathology seen in susceptible neurons. The sources of ROS-mediated damage appear to be multi-faceted in AD, with interactions between abnormal mitochondria, redox transition metals, and other factors. In this review, we provide an overview of these potential causes of oxidative stress in AD.

Integrity signals

Registry

Crossref · 10.1007/s00018-007-7218-4

Cites

117 of 117 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
The Ubiquitin-Proteasome Proteolytic Pathway: Destruction for the Sake of Construction
Glickman, M. H., & Ciechanover, A. J. (2002) · Physiological Reviews · doi:10.1152/physrev.00027.2001 · Cited by 4,304
Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
Seshadri, S., Beiser, A., Selhub, J., Jacques, P. F., Rosenberg, I. H., D'Agostino, R. B., Wilson, P. W. F., & Wolf, P. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011613 · Cited by 3,237
Copper, iron and zinc in Alzheimer's disease senile plaques
Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L., & Markesbery, W. R. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00092-6 · Cited by 2,120
Hydrogen peroxide mediates amyloid β protein toxicity
Behl, C. (1994) · Cell · doi:10.1016/0092-8674(94)90131-7 · Cited by 2,074
Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease
Minoshima, S., Giordani, B., Berent, S., Frey, K. A., Foster, N. L., & Kuhl, D. E. (1997) · Annals of Neurology · doi:10.1002/ana.410420114 · Cited by 1,802
Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids
Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., Schiossmacher, M., Whaley, J., Swindlehurst, C., et al. (1992) · Nature · doi:10.1038/359325a0 · Cited by 1,731
APP Processing and Synaptic Function
Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S., & Malinow, R. (2003) · Neuron · doi:10.1016/s0896-6273(03)00124-7 · Cited by 1,644
Extensive Involvement of Autophagy in Alzheimer Disease: An Immuno-Electron Microscopy Study
Nixon, R. A., Wegiel, J., Kumar, A., Yu, W. H., Peterhoff, C., Cataldo, A., & Cuervo, A. M. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.2.113 · Cited by 1,588
Iron accumulation in Alzheimer disease is a source of redox-generated free radicals
Smith, M. A., Harris, P. L. R., Sayre, L. M., & Perry, G. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9866 · Cited by 1,365
Self-citation
ABAD Directly Links Aß to Mitochondrial Toxicity in Alzheimer's Disease
Lustbader, J. W., Cirilli, M., Lin, C., Xu, H. W., Takuma, K., Wang, N., Caspersen, C., Chen, X., Pollak, S., Chaney, M., et al. (2004) · Science · doi:10.1126/science.1091230 · Cited by 1,303
Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.
Smith, C. D., Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Stadtman, E. R., Floyd, R. A., & Markesbery, W. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10540 · Cited by 1,296
Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease
Smith, M. A., Richey Harris, P. L., Sayre, L. M., Beckman, J. S., & Perry, G. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02653.1997 · Cited by 1,239
Self-citation
The Aβ Peptide of Alzheimer's Disease Directly Produces Hydrogen Peroxide through Metal Ion Reduction
Huang, X., Atwood, C., Hartshorn, M. A., Multhaup, G., Goldstein, L. E., Scarpa, R. C., Cuajungco, M. P., Gray, D. N., Lim, J. T., Moir, R. D., et al. (1999) · Biochemistry · doi:10.1021/bi990438f · Cited by 1,117
Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid β-peptide
Butterfield, D. A., Drake, J., Pocernich, C., & Castegna, A. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02173-6 · Cited by 1,114
Mitochondria are a direct site of Aβ accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression
Manczak, M., Anekonda, T. S., Henson, E., Park, B. S., Quinn, J., & Reddy, P. H. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl066 · Cited by 1,104
4‐Hydroxynonenal‐Derived Advanced Lipid Peroxidation End Products Are Increased in Alzheimer's Disease
Sayre, L., Zelasko, D. A., Harris, P. L. R., Perry, G., Salomon, R. G., & Smith, M. A. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68052092.x · Cited by 1,032
Self-citation
Oxidative damage in Alzheimer's
Smith, M. A., Perry, G. L., Richey, P. L., Sayrec, L. M., Anderson, V. E., Beal, M. F., & Kowall, N. W. (1996) · Nature · doi:10.1038/382120b0 · Cited by 897
Self-citation
Impaired Proteasome Function in Alzheimer's Disease
Keller, J. N., Hanni, K. B., & Markesbery, W. R. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750436.x · Cited by 848
Advanced glycation end products contribute to amyloidosis in Alzheimer disease
Vitek, M. P., Bhattacharya, K., Glendening, J. M., Stopa, E., Vlassara, H., Bucala, R., Manogue, K., & Cerami, A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.4766 · Cited by 806
Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction
Devi, L., Prabhu, B. M., Galati, D. F., Avadhani, N. G., & Anandatheerthavarada, H. K. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1469-06.2006 · Cited by 792
A Role for 4‐Hydroxynonenal, an Aldehydic Product of Lipid Peroxidation, in Disruption of Ion Homeostasis and Neuronal Death Induced by Amyloid β‐Peptide
Mark, R. J., Lovell, M. A., Markesbery, W. R., Uchida, K., & Mattson, M. P. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68010255.x · Cited by 783
RNA Oxidation Is a Prominent Feature of Vulnerable Neurons in Alzheimer’s Disease
Nunomura, A., Perry, G., Pappolla, M., Wade, R., Hirai, K., Chiba, S., & Smith, M. A. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-06-01959.1999 · Cited by 768
Self-citation
Review: Alzheimer's Amyloid β-Peptide-Associated Free Radical Oxidative Stress and Neurotoxicity
Varadarajan, S., Yatin, S., Aksenova, M., & Butterfield, D. A. (2000) · Journal of Structural Biology · doi:10.1006/jsbi.2000.4274 · Cited by 735
The mitochondrial‐lysosomal axis theory of aging
Brunk, U. T., & Terman, A. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.02869.x · Cited by 729
Advanced Maillard reaction end products are associated with Alzheimer disease pathology.
Smith, M. A., Taneda, S., Richey, P. L., Miyata, S., Yan, S. D., Stern, D., Sayre, L. M., Monnier, V. M., & Perry, G. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5710 · Cited by 715
Self-citation
Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease
Markesbery, W. R., & Lovell, M. A. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00009-8 · Cited by 680
Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease
Lovell, M. A., Ehmann, W. D., Butler, S. M., & Markesbery, W. R. (1995) · Neurology · doi:10.1212/wnl.45.8.1594 · Cited by 644
Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites of Alzheimer disease brains.
Perry, G., Friedman, R., Shaw, G., & Chau, V (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.9.3033 · Cited by 623
Self-citation
Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication
Coskun, P. E., Beal, M. F., & Wallace, D. C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403649101 · Cited by 556
Amyloid β-Peptide Impairs Glucose Transport in Hippocampal and Cortical Neurons: Involvement of Membrane Lipid Peroxidation
Mark, R. J., Pang, Z., Geddes, J. W., Uchida, K., & Mattson, M. P. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-03-01046.1997 · Cited by 551
Proteomic identification of nitrated proteins in Alzheimer's disease brain
Castegna, A., Thongboonkerd, V., Klein, J. B., Lynn, B. C., Markesbery, W. R., & Butterfield, D. A. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01786.x · Cited by 535
Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro
Podrez, E. A., Schmitt, D. C., Hoff, H. F., & Hazen, S. L. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5549 · Cited by 500
A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients
Maurer, I. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00112-3 · Cited by 475
Radical AGEing in Alzheimer's disease
Smith, M. A., Sayre, L. M., Monnier, V. M., & Perry, G. L. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)93897-7 · Cited by 462
Self-citation
The toxicity in vitro of β-amyloid protein
Iversen, L. L., Mortishire‐Smith, R. J., Pollack, S. J., & Shearman, M. S. (1995) · Biochemical Journal · doi:10.1042/bj3110001 · Cited by 428
Redox-active iron mediates amyloid-β toxicity
Rottkamp, C. A., Raina, A. K., Zhu, X., Gaier, E., Bush, A. I., Atwood, C., Chevion, M., Perry, G. L., & Smith, M. A. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00494-9 · Cited by 379
Self-citation
Role of mitochondrial dysfunction in Alzheimer's disease
Castellani, R. J., Hirai, K., Aliev, G. M., Drew, K. L., Nunomura, A., Takeda, A., Cash, A., Obrenovich, M. E., Perry, G. L., & Smith, M. A. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10389 · Cited by 366
Self-citation
The myeloperoxidase system of human phagocytes generates Nε-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation
Anderson, M. M., Requena, J. R., Crowley, J. R., Thorpe, S. R., & Heinecke, J. W. (1999) · Journal of Clinical Investigation · doi:10.1172/jci3042 · Cited by 349
Abnormalities of mitochondrial enzymes in Alzheimer disease
Gibson, G. E., Sheu, K.-F. R., & Blass, J. P. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050099 · Cited by 345
Neuronal Oxidative Stress Precedes Amyloid-β Deposition in Down Syndrome
Nunomura, A., Perry, G. L., Pappolla, M. A., Friedland, R. P., Hirai, K., Chiba, S., & Smith, M. A. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.11.1011 · Cited by 324
Self-citation
Myeloperoxidase Polymorphism Is Associated with Gender Specific Risk for Alzheimer's Disease
Reynolds, W. F., Rhees, J., Maciejewski, D. F., Paladino, T., Sieburg, H. B., Maki, R. A., & Masliah, E. (1999) · Experimental Neurology · doi:10.1006/exnr.1998.6977 · Cited by 321
Impairment of the ubiquitin‐proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures
McNaught, K. S. P., Mytilineou, C., JnoBaptiste, R., Yabut, J. A., Shashidharan, P., Jenner, P. G., & Olanow, C. W. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00821.x · Cited by 310
Alzheimer's disease – synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts
Münch, G. W., Schinzel, R., Loske, C., Wong, A. O., Durany, N., Li, J. J., Vlassara, H., Smith, M. A., Perry, G. L., & Riederer, P. F. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050069 · Cited by 305
Self-citation
Lysosomal enzymes promote mitochondrial oxidant production, cytochrome c release and apoptosis
Zhao, M., Antunes, F., Eaton, J. W., & Brunk, U. T. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03765.x · Cited by 291
Ribosomal RNA in Alzheimer Disease Is Oxidized by Bound Redox-active Iron
Honda, K., Smith, M. A., Zhu, X., Baus, D., Merrick, W. C., Tartakoff, A. M., Hattier, T., Harris, P. L., Siedlak, S. L., Fujioka, H., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500526200 · Cited by 280
Self-citation
Lipofuscin and Aging: A Matter of Toxic Waste
Gray, D. A., & Woulfe, J. (2005) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2005.5.re1 · Cited by 279
Advanced glycation endproducts in ageing and Alzheimer's disease
Münch, G. W., Thome, J., Foley, P. B., Schinzel, R., & Riederer, P. F. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(96)00016-1 · Cited by 278
A novel hypothesis of lipofuscinogenesis and cellular aging based on interactions between oxidative stress and autophagocytosis
Brunk, U. T., Jones, C. B., & Sohal, R. S. (1992) · Mutation Research/DNAging · doi:10.1016/0921-8734(92)90042-n · Cited by 274
Lysosomal hydrolases of different classes are abnormally distributed in brains of patients with Alzheimer disease.
Cataldo, A. M., Paskevich, P. A., Kominami, E., & Nixon, R. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.10998 · Cited by 269
The proteasome in brain aging
Keller, J. (2002) · Ageing Research Reviews · doi:10.1016/s1568-1637(01)00006-x · Cited by 247
Carbonyl‐Related Posttranslational Modification of Neurofilament Protein in the Neurofibrillary Pathology of Alzheimer's Disease
Smith, M. A., Rudnicka-Nawrot, M., Richey, P., Praprotnik, D., Mulvihill, P., Miller, C., Sayre, L., & Perry, G. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64062660.x · Cited by 240
Self-citation
Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders
Loeffler, D. A., LeWitt, P. A., Juneau, P. L., Sima, A. A. F., Nguyen, H.-U., DeMaggio, A. J., Brickman, C. M., Brewer, G. J., Dick, R. D., Troyer, M. D., et al. (1996) · Brain Research · doi:10.1016/s0006-8993(96)00782-2 · Cited by 237
Decrease and Structural Modifications of Phosphatidylethanolamine Plasmalogen in the Brain with Alzheimer Disease
Guan, Z., Wang, Y., Cairns, N. J., Lantos, P. L., Dallner, G., & Sindelar, P. J. (1999) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199907000-00008 · Cited by 236
Lysosomal involvement in apoptosis
Brunk, U. T., Neužil, J., & Eaton, J. W. (1998) · Pathophysiology · doi:10.1016/s0928-4680(98)80586-5 · Cited by 232
Correlation of Astrocytic S100β Expression with Dystrophic Neurites in Amyloid Plaques of Alzheimerʼs Disease
Mrak, R. E., Sheng, J. G., & Griffin, W. S. T. (1996) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199603000-00002 · Cited by 230
Amyloid-β Peptides Are Cytotoxic to Oligodendrocytes
Xu, J., Chen, S., Ahmed, S. H., Chen, H., Ku, G., Goldberg, M. P., & Hsu, C. Y. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-01-j0001.2001 · Cited by 230
Aberrant expression of NOS isoforms in Alzheimer’s disease is structurally related to nitrotyrosine formation
Lüth, H., Münch, G. W., & Arendt, T. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03280-8 · Cited by 223
Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer disease.
Chandrasekaran, K., Giordano, T., Brady, D., Stoll, J., Martin, L. J., & Rapoport, S. (1994) · Brain Research. Molecular Brain Research · doi:10.1016/0169-328x(94)90147-3 · Cited by 221
The role of complement and activated microglia in the pathogenesis of Alzheimer's disease
Eikelenboom, P., & Veerhuis, R. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00108-x · Cited by 206
Proteasome Inhibition Alters Neural Mitochondrial Homeostasis and Mitochondria Turnover
Sullivan, P. G., Dragicevic, N., Deng, J., Bai, Y., Dimayuga, E. R., Ding, Q., Chen, Q., Bruce‐Keller, A. J., & Keller, J. N. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313579200 · Cited by 202
Reduced platelet cytochrome c oxidase activity in Alzheimer's disease
Parker, W. D., Mahr, N., Filley, C. M., Parks, J. K., Hughes, D., Young, D. A., & Cullum, C. M. (1994) · Neurology · doi:10.1212/wnl.44.6.1086 · Cited by 199
Active glycation in neurofibrillary pathology of Alzheimer disease: Nε-(Carboxymethyl) lysine and hexitol-lysine
Castellani, R. J., Harris, P. L. R., Sayre, L. M., Fujii, J., Taniguchi, N., Vitek, M. P., Founds, H., Atwood, C., Perry, G. L., & Smith, M. A. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00570-6 · Cited by 198
Self-citation
Differential Impairment of 20S and 26S Proteasome Activities in Human Hematopoietic K562 Cells during Oxidative Stress
Reinheckel, T., Ullrich, O., Sitte, N., & Grune, T. (2000) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2000.1717 · Cited by 194
Amyloid-β and τ serve antioxidant functions in the aging and Alzheimer brain
Smith, M. A., Casadesús, G., Joseph, J. A., & Perry, G. L. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01021-3 · Cited by 189
Self-citation
Lysosomal abnormalities in degenerating neurons link neuronal compromise to senile plaque development in Alzheimer disease
Cataldo, A. M., Hamilton, D. J., & Nixon, R. A. (1994) · Brain Research · doi:10.1016/0006-8993(94)91858-9 · Cited by 185
Challenging the Amyloid Cascade Hypothesis: Senile Plaques and Amyloid‐β as Protective Adaptations to Alzheimer Disease
Lee, H., Casadesús, G., Zhu, X., Takeda, A., Perry, G. L., & Smith, M. A. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1297.001 · Cited by 183
Self-citation
Expression of endothelial and inducible NOS-isoforms is increased in Alzheimer’s disease, in APP23 transgenic mice and after experimental brain lesion in rat: Evidence for an induction by amyloid pathology
Lüth, H.-J., Holzer, M., Gärtner, U., Staufenbiel, M., & Arendt, T. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02758-5 · Cited by 183
Amyloid-β is an antioxidant for lipoproteins in cerebrospinal fluid and plasma
Kontush, A., Berndt, C., Weber, W., Akopyan, V., Arlt, S., Schippling, S., & Beisiegel, U. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00458-5 · Cited by 180
Antioxidant Potential of Anaerobic Human Plasma: Role of Serum Albumin and Thiols as Scavengers of Carbon Radicals
Soriani, M., Pietraforte, D., & Minetti, M. (1994) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1994.1297 · Cited by 180
Amyloid-β: an antioxidant that becomes a pro-oxidant and critically contributes to Alzheimer’s disease
Kontush, A. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00688-8 · Cited by 178
Lysosomal proteinase antigens are prominently localized within senile plaques of Alzheimer's disease: evidence for a neuronal origin
Cataldo, A. M., Thayer, C. Y., Bird, E. D., Wheelock, T. R., & Nixon, R. A. (1990) · Brain Research · doi:10.1016/0006-8993(90)90456-l · Cited by 176
Selective increase in lipid peroxidation in the inferior temporal cortex in Alzheimer's disease
Palmer, A. M., & Burns, M. A. (1994) · Brain Research · doi:10.1016/0006-8993(94)91670-5 · Cited by 171
Mitochondrial enzyme-deficient hippocampal neurons and choroidal cells in AD
Cottrell, D. A., Blakely, E. L., Johnson, M. A., Ince, P. G., & Turnbull, D. M. (2001) · Neurology · doi:10.1212/wnl.57.2.260 · Cited by 163
Iron in cytosolic ferritin can be recycled through lysosomal degradation in human fibroblasts
Radisky, D. C., & Kaplan, J. (1998) · Biochemical Journal · doi:10.1042/bj3360201 · Cited by 163
The Role of Iron in Beta Amyloid Toxicity
Schubert, D. A., & Chevion, M. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2678 · Cited by 159
Increased protein glycation in cerebrospinal fluid of Alzheimer’s disease 2 2Abbreviations: AD, Alzheimer’s disease; AGEs, advanced glycation end products; apo, apolipoprotein; BSA, bovine serum albumin; CSF, cerebrospinal fluid; ELISA, enzyme-linked immunosorbent assay; PBS, phosphate buffer saline.
Shuvaev, V. V., Laffont-Proust, I., Sérot, J., Fujii, J., Taniguchi, N., & Siest, G. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00253-0 · Cited by 153
Copper/zinc ratio and systemic oxidant load: effect of aging and aging-related degenerative diseases
Mezzetti, A., Pierdomenico, S. D., Costantini, F., Romano, F., Cesare, D. D., Cuccurullo, F., Imbastaro, T., Riario-Sforza, G., Giacomo, F. D., Zuliani, G., et al. (1998) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00109-9 · Cited by 151
Metabolic, Metallic, and Mitotic Sources of Oxidative Stress in Alzheimer Disease
Smith, M. A., Nunomura, A., Zhu, X., Takeda, A., & Perry, G. L. (2000) · Antioxidants and Redox Signaling · doi:10.1089/15230860050192198 · Cited by 151
Self-citation
Advanced Maillard Reaction End Products, Free Radicals, and Protein Oxidation in Alzheimer's Diseasea
Smith, M. A., Richey, P. L., Taneda, S., Kutty, R. K., Lm, S., Monnier, V. M., & Perry, G. L. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb21836.x · Cited by 147
Self-citation
Promotion of transition metal-induced reactive oxygen species formation by β-amyloid
Bondy, S. C., Guo‐Ross, S. X., & Truong, A. T. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00461-2 · Cited by 139
Characterization of chronic low‐level proteasome inhibition on neural homeostasis
Ding, Q., Dimayuga, E. R., Martin, S. K., Bruce‐Keller, A. J., Nukala, V. N., Cuervo, A. M., & Keller, J. N. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01885.x · Cited by 131
The Nitration Product 5-Nitro-γ-tocopherol Is Increased in the Alzheimer Brain
Williamson, K. S., Gabbita, S. P., Mou, S., West, M. S., Pye, Q. N., Markesbery, W. R., Cooney, R. V., Grammas, P., Reimann‐Philipp, U., Floyd, R. A., et al. (2002) · Nitric Oxide · doi:10.1006/niox.2001.0399 · Cited by 131
Alzheimer’s amyloid β-peptide (1–42): involvement of methionine residue 35 in the oxidative stress and neurotoxicity properties of this peptide
Butterfield, D. A., & Bush, A. I. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.12.027 · Cited by 129
Mitochondrial failures in Alzheimer's disease
Zhu, X., Smith, M. A., Perry, G. L., & Aliev, G. (2004) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/153331750401900611 · Cited by 125
Self-citation
Neuronal RNA Oxidation in Alzheimer's Disease and Down's Syndrome
Nunomura, A., Perry, G. L., Hirai, K., Aliev, G., Takeda, A., Chiba, S., & Smith, M. A. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07855.x · Cited by 112
Self-citation
Abnormal distribution of cathepsins in the brain of patients with Alzheimer's disease
Nakamura, Y., Takeda, M., Suzuki, H., Hattori, H., Tada, K., Hariguchi, S., Hashimoto, S., & Nishimura, T. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90395-a · Cited by 111
Involvement of maillard reactions in Alzheimer disease
Reddy, V. P., Obrenovich, M. E., Atwood, C., Perry, G. L., & Smith, M. A. (2002) · Neurotoxicity Research · doi:10.1080/1029840290007321 · Cited by 101
Self-citation
Alzheimer disease: Evidence for a central pathogenic role of iron-mediated reactive oxygen species
Casadesús, G., Smith, M. A., Zhu, X., Aliev, G. M., Cash, A., Honda, K., Petersen, R. B., & Perry, G. L. (2004) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6208 · Cited by 101
Self-citation
Role of the proteasome in protein oxidation and neural viability following low‐level oxidative stress
Ding, Q., Reinacker, K., Dimayuga, E. R., Nukala, V. N., Drake, J., Butterfield, D. A., Dunn, J. C., Martin, S. K., Bruce‐Keller, A. J., & Keller, J. N. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00582-9 · Cited by 89
Modulation of Ca2+ channel currents in primary cultures of rat cortical neurones by amyloid β protein (1–40) is dependent on solubility status
Ramsden, M., Henderson, Z., & Pearson, H. A. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03547-3 · Cited by 87
Is increased redox-active iron in Alzheimer disease a failure of the copper-binding protein ceruloplasmin?
Castellani, R., Smith, M. A., Nunomura, A., Harris, P., & Perry, G. (1999) · Free Radical Biology & Medicine · doi:10.1016/s0891-5849(99)00016-7 · Cited by 87
Self-citation
Cerebromicrovascular Pathology in Alzheimer’s Disease Compared to Normal Aging
de la Torre, J. C. (2009) · Gerontology · doi:10.1159/000213834 · Cited by 86
Amyloid β Protein Primes Cultured Rat Microglial Cells for an Enhanced Phorbol 12‐Myristate 13‐Acetate‐Induced Respiratory Burst Activity
Van Muiswinkel, F. L., Veerhuis, R., & Eikelenboom, P. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66062468.x · Cited by 85
Mitochondrial enzyme expression in the hippocampus in relation to Alzheimer-type pathology
Nagy, Z., Esiri, M. M., LeGris, M., & Matthews, P. M. (1999) · Acta Neuropathologica · doi:10.1007/s004010050997 · Cited by 85
The state versus amyloid-β: the trial of the most wanted criminal in Alzheimer disease
Rottkamp, C. A., Atwood, C., Joseph, J. A., Nunomura, A., Perry, G. L., & Smith, M. A. (2002) · Peptides · doi:10.1016/s0196-9781(02)00069-4 · Cited by 81
Self-citation
Is hemochromatosis a risk factor for Alzheimer's disease?
Connor, J. R., Milward, E. A., Moalem, S., Sampietro, M., Boyer, P. J., Percy, M. E., Vergani, C., Scott, R. J., & Chorney, M. J. (2001) · Journal of Alzheimer s Disease · doi:10.3233/jad-2001-3506 · Cited by 80
Differential effects of unaggregated and aggregated amyloid β protein (1–40) on K+ channel currents in primary cultures of rat cerebellar granule and cortical neurones
Ramsden, M., Plant, L. D., Webster, N. J., Vaughan, P. F. T., Henderson, Z., & Pearson, H. A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00618.x · Cited by 76
Apolipoprotein E allele–dependent antioxidant activity in brains with Alzheimer’s disease
Tamaoka, A., Miyatake, F., Matsuno, S., Ishii, K., Nagase, S., Sahara, N., Ono, S., Mori, H., Wakabayashi, K., Tsuji, S., et al. (2000) · Neurology · doi:10.1212/wnl.54.12.2319 · Cited by 70
Physiological thiol compounds exert pro- and anti-oxidant effects, respectively, on iron- and copper-dependent oxidation of human low-density lipoprotein
Lynch, S. M., & Frei, B. B. (1997) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/s0005-2760(96)00182-8 · Cited by 68
An immunochemical study on tau glycation in paired helical filaments
Ko, L., Ko, E. C., Nacharaju, P., Liu, W.-K., Chang, E. C., Kenessey, Á., & Yen, S.-H. C. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01415-8 · Cited by 68
Cerebrometabolic Aspects of Delirium in Relationship to Dementia
Blass, J. P., & Gibson, G. E. (1999) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017165 · Cited by 68
Age-dependent accumulation of advanced glycosylation end products in human neurons
Li, J., Surini, M., Catsicas, S., Kawashima, E. H., & Bouras, C. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)80009-g · Cited by 66
A glycation connection
Harrington, C. R., & Colaco, C. A. L. S. (1994) · Nature · doi:10.1038/370247a0 · Cited by 60
Cellular cofactors potentiating induction of stress and cytotoxicity by amyloid β-peptide
Yan, S. D., Roher, A. E., Chaney, M., Zloković, B. V., Schmidt, A. M., & Stern, D. M. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00041-7 · Cited by 58
Antiinflammatory activity of methionine, methionine sulfoxide and methionine sulfone
Unnikrishnan, M. K., & Rao, M. N. A. (1990) · Inflammation Research · doi:10.1007/bf02003229 · Cited by 54
Electron Transport Chain Defects in Alzheimer's Disease
Schapira, A. H. V., & Reichmann, H. (1995) · Neurology · doi:10.1212/wnl.45.3.599-a · Cited by 54
The proteasome in Alzheimer's disease and Parkinson's disease: lessons from ubiquitin B+1
Hol, E. M., van Leeuwen, F. W., & Fischer, D. F. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.09.001 · Cited by 52
Advanced glycation endproducts — associated parameters in the peripheral blood of patients with Alzheimer's disease
Thome, J., Münch, G. W., Müller, R., Schinzel, R., Kornhuber, J., Blum-Degen, D., Sitzmann, L., Rösler, M., Heidland, A., & Riederer, P. F. (1996) · Life Sciences · doi:10.1016/0024-3205(96)00349-9 · Cited by 50
Alzheimer's Disease Amyloid β Peptide 25-35 Inhibits Lipid Peroxidation as a Result of Its Membrane Interactions
Walter, M. F., Mason, P. E., & Mason, R. P. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6547 · Cited by 44
Antigenic expression of cathepsin B in aged human brain
Bernstein, H., Kirschke, H., Wiederanders, B., Schmidt, D., & Rinne, A. (1990) · Brain Research Bulletin · doi:10.1016/0361-9230(90)90157-u · Cited by 43
Impairment of energy metabolism in hippocampus of rats subjected to chemically-induced hyperhomocysteinemia
STRECK, E. L., Matté, C., Vieira, P. S., Calcagnotto, T., Wannmacher, C. M. D., Wajner, M., & Wyse, Â. T. D. S. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(03)00019-x · Cited by 41
Tl 2+ and Ag 2+ Metal-ion-induced Oxidation of Methionine in Aqueous Solution. A Pulse Radiolysis Study
HILLER, K. ‐., & Asmus, K. D. (1981) · International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine · doi:10.1080/09553008114551581 · Cited by 40
Intermediary metabolism disturbance in AD/SDAT and its relation to molecular events
Hoyer, S. (1993) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(93)90043-r · Cited by 26
The induction of surface β-amyloid binding proteins and enhanced cytotoxicity in cultured PC-12 and IMR-32 cells by advanced glycation end products
Mruthinti, S., Sood, A., Humphrey, C., Swamy-Mruthinti, S., & Buccafusco, J. J. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.06.010 · Cited by 21
A? peptides and calcium influence secretion of the amyloid protein precursor from chick sympathetic neurons in culture
Mok, S. S., Clippingdale, A. B., Beyreuther, K. T., Masters, C. L., Barrow, C. J., & Small, D. H. (2000) · Journal of Neuroscience Research · doi:10.1002/1097-4547(20000815)61:4 · Cited by 10
Untitled work
Klegeris (1997) · doi:10.1002/(sici)1097-4547(19970715)49:2

Sorted by citations

The role of antioxidants in the chemistry of oxidative stress: A review
Pisoschi, A. M., & Pop, A. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.04.040 · Cited by 2,963
Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs
Agrawal, M., Saraf, S., Saraf, S., Antimisiaris, S. G., Chougule, M. B., Shoyele, S. A., & Alexander, A. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.05.011 · Cited by 630
Amyloid β Protein and Alzheimer’s Disease: When Computer Simulations Complement Experimental Studies
Nasica-Labouze, J., Nguyen, P. H., Sterpone, F., Berthoumieu, O., Buchete, N., Côté, S., Simone, A. D., Doig, A. J., Faller, P., García, A. E., et al. (2015) · Chemical Reviews · doi:10.1021/cr500638n · Cited by 591
Age-dependent deterioration of nuclear pore complexes causes a loss of nuclear integrity in postmitotic cells.
D'Angelo, M. A., Raices, M., Panowski, S. H., & Hetzer, M. W. (2009) · Cell · doi:10.1016/j.cell.2008.11.037 · Cited by 565
Microglial cell dysregulation in brain aging and neurodegeneration
von Bernhardi, R., Eugenín-von Bernhardi, L., & Eugenín, J. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00124 · Cited by 556

See all 344

Authors: Zhu, X., Su, B., Wang, X., Smith, M. A., & Perry, G.
Affiliations: Case Western Reserve University (US)
The University of Texas at San Antonio (US)
Corresponding author: Perry, G.
ORCID: Zhu, X.
Su, B.
Wang, X.
Smith, M. A.
Perry, G.
Venue: Cellular and Molecular Life Sciences
Publisher: Springer Science and Business Media LLC
Published: 2007-07-02
Volume: 64
Issue: 17
Pages: 2202-2210
ISSN: 1420-682X (ISSN-L)
1420-9071
DOI: 10.1007/s00018-007-7218-4
PMC: PMC11136009
OpenAlex: W2064625375
Cited by: 336
References: 117
Citations by year: 2026: 3 · 2025: 4 · 2024: 6 · 2023: 12 · 2022: 10 · 2021: 9 · 2020: 17 · 2019: 12 · 2018: 16 · 2017: 16 · 2016: 10 · 2015: 26 · 2014: 28 · 2013: 11 · 2012: 38
FWCI: 20.92
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Cellular and Molecular Life Sciences (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords: oxidative stress, Alzheimer's disease, reactive oxygen species, mitochondrial dysfunction, neurodegeneration, neuronal injury, pathogenesis
MeSH terms: Alzheimer Disease, Astrocytes, Copper, Glycosylation, Humans, Iron, Mitochondria, Oxidation-Reduction, Glycation End Products, Advanced, Reactive Oxygen Species, Microglia, Oxidative Stress

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Causes of oxidative stress in Alzheimer disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks